Type 1 interferons as a potential treatment against COVID-19

Type 1 interferons have a broad antiviral activity in vitro and are currently evaluated in a clinical trial to treat MERS-CoV. In this review, we discuss preliminary data concerning the potential activity of type 1 interferons on SARS-CoV-2, and the relevance of evaluating these molecules in clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Sallard, Erwan, Lescure, François-Xavier, Yazdanpanah, Yazdan, Mentre, France, Peiffer-Smadja, Nathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138382/
https://www.ncbi.nlm.nih.gov/pubmed/32275914
http://dx.doi.org/10.1016/j.antiviral.2020.104791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138382/
https://www.ncbi.nlm.nih.gov/pubmed/32275914
http://dx.doi.org/10.1016/j.antiviral.2020.104791

Ejemplares similares